sulfonylurea and glp 1 GLP-1 the kidney: from physiology to pharmacology and outcomes in diabetes Drugs for Diabetes Mellitus
Description
10.1007/s00213-025-06834-7
The active ingredient in semaglutide GLP-1 injections is a type of GLP-1 receptor agonist
TEXT ON-SCREEN: , 6
Semaglutide was removed from the FDA's drug shortage list in February 2025, and tirzepatide followed in December 2024
Frequently asked questions 1
Essentially, GLP-1 medicationsshort for Glucagon-Like Peptide-1 receptor agonistsmimic a hormone that helps control blood sugar, curb appetite, and even boost heart health
